Citicoline, Creatine, and Omega-3 Effects in Middle Age Women
Sponsor: Deborah Yurgelun-Todd
Listed as NCT01502813, this NA trial focuses on Cognitive Benefits and remains completed. Sponsored by Deborah Yurgelun-Todd, it has been updated 11 times since 2012, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
May 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 6 earlier versions
-
Jan 2021 — May 2021 [monthly]
Completed NA
-
Dec 2019 — Jan 2021 [monthly]
Completed NA
-
May 2019 — Dec 2019 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jun 2018 — May 2019 [monthly]
Active Not Recruiting NA
-
Feb 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting NA
First recorded
Feb 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Deborah Yurgelun-Todd
For direct contact, visit the study record on ClinicalTrials.gov .